Zangmeister Cancer Center Announces Partnership with Sarah Cannon Research Institute to Expand Patient Access to Community-Based Clinical Research
Zangmeister Cancer Center to offer cutting-edge research to patients in Columbus, Ohio through new partnership
Columbus, Ohio, Apr. 19, 2021 – Zangmeister Cancer Center (Zangmeister), a partner practice of American Oncology Network, LLC (AON), recently aligned with the Sarah Cannon Research Institute, a global leader in offering community-based clinical trials.
Zangmeister has partnered with Sarah Cannon Research Institute to expand access to cutting-edge cancer research through clinical trials for patients in the community. Zangmeister physicians deliver the most advanced cancer treatments customized for each patient so they can achieve the best possible outcome. The cancer center offers convenient access to comprehensive treatments and support services close to where the patient lives. Having in-house laboratory, pathology and oral pharmacy services all under one roof makes it easier for patients to receive the care they need in one location. Through the partnership with Sarah Cannon Research Institute, clinical trials will now be offered as part of Zangmeister’s oncology services at its cancer center in Columbus, Ohio.
Zangmeister Medical Oncologist Dr. Jeanna Knoble said, “Cancer treatment is evolving rapidly. Targeted therapies allow us to limit toxicity, analyzing the genetics of each patient’s tumor allows us to truly personalize each plan of care. This collaboration with Sarah Cannon Research Institute will expand patient access to pioneering research and innovative treatments within the community. It shows our commitment to not only improving the lives and the health our patients but also the community.”
Zangmeister Medical Oncologist Dr. Mark Knapp added, “Clinical trials and research allow us to understand a patient’s tumor more quickly, discovering what’s driving the cancer and finding targeted therapies to treat it. Our partnership with Sarah Cannon Research Institute will help us further improve the quality of life of our patients during and after treatment.”
Zangmeister Medical Oncologists serving patients in Columbus are Dr. Tarek Chidiac, Dr. Patrick Elwood, Dr. Mark Knapp, Dr. Jeanna Knoble, Dr. Sameh Mikhail, Dr. Timothy Moore, Dr. Taral Patel, Dr. Jorge Rios, Dr. Mark Segal, Dr. Kothai Sundaram, Dr. Emily Whitman, Dr. Jeffrey Zangmeister and Gynecologic Oncologist Dr. Luis Vaccarello. Providing comprehensive cancer care in one central location, Zangmeister also offers patients care management services through their affiliation with AON.
AON is an alliance of physicians and seasoned healthcare leaders that provides a unique array of enhanced services to its affiliated community-based oncology practices. It consistently strives to find innovative ways to connect with patients. AON’s community oncology model allows physicians to focus on what matters most — their patients.
About Zangmeister Cancer Center: (ZangCenter.com)
The Zangmeister Cancer Center is dedicated to providing the best quality care for our patients and families. We adhere to a holistic approach to patient care. We provide the most advanced technological care while meeting the physical, social, emotional, economic and spiritual needs of each individual we serve.
About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network currently represents 92 physicians and 62 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.
The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per capita cost of cancer care.
AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.
About Sarah Cannon Research Institute (SarahCannon.com)
Sarah Cannon Research Institute is the research arm of HCA Healthcare’s Cancer Institute, Sarah Cannon. Focused on advancing therapies for patients, it is one of the world’s leading clinical research organizations conducting community-based clinical trials throughout the United States and United Kingdom. A leader in drug development, Sarah Cannon has led more than 500 first-in-human clinical trials since its inception in 1993, and has been a clinical trial leader in the majority of approved cancer therapies over the last 10 years. Additionally, Sarah Cannon offers management, regulatory, and other research support services for drug development and industry sponsors as well as strategic investigator sites through its contract research organization (CRO), Sarah Cannon Development Innovations.
For More Information, Contact:
American Oncology Network, LLC
Vice President of Marketing